End-of-day quote
Korea S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
33,800
KRW
|
+0.45%
|
|
-0.15%
|
-11.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
532,810
|
668,301
|
564,513
|
344,828
|
455,944
|
401,326
|
-
|
-
|
Enterprise Value (EV)
2 |
512.6
|
702.4
|
536.7
|
344.8
|
506.6
|
447.3
|
423.9
|
390.6
|
P/E ratio
|
12.7
x
|
11
x
|
15.2
x
|
15.4
x
|
9.32
x
|
7.91
x
|
6.94
x
|
-
|
Yield
|
1.3%
|
0.97%
|
1.26%
|
2.06%
|
1.64%
|
1.86%
|
1.82%
|
1.86%
|
Capitalization / Revenue
|
1.46
x
|
1.64
x
|
1.29
x
|
0.7
x
|
0.83
x
|
0.64
x
|
0.59
x
|
0.54
x
|
EV / Revenue
|
1.4
x
|
1.73
x
|
1.23
x
|
0.7
x
|
0.92
x
|
0.71
x
|
0.62
x
|
0.52
x
|
EV / EBITDA
|
8.8
x
|
10.6
x
|
8.6
x
|
5.99
x
|
9.04
x
|
5.37
x
|
4.65
x
|
3.97
x
|
EV / FCF
|
22.4
x
|
79.9
x
|
-
|
-
|
-
|
13.2
x
|
9.22
x
|
-
|
FCF Yield
|
4.46%
|
1.25%
|
-
|
-
|
-
|
7.6%
|
10.9%
|
-
|
Price to Book
|
2.49
x
|
2.79
x
|
1.93
x
|
1.22
x
|
1.4
x
|
1.1
x
|
0.96
x
|
-
|
Nbr of stocks (in thousands)
|
11,939
|
11,895
|
11,835
|
11,829
|
11,874
|
11,874
|
-
|
-
|
Reference price
3 |
44,628
|
56,182
|
47,700
|
29,150
|
38,400
|
33,800
|
33,800
|
33,800
|
Announcement Date
|
3/11/20
|
2/15/21
|
2/16/22
|
2/14/23
|
3/20/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
365
|
406.7
|
436.9
|
492.4
|
552
|
631.8
|
684.9
|
747.6
|
EBITDA
1 |
58.23
|
65.95
|
62.45
|
57.6
|
56.02
|
83.3
|
91.2
|
98.5
|
EBIT
1 |
48.4
|
54.12
|
49.6
|
40.87
|
56
|
59.6
|
70.45
|
73.8
|
Operating Margin
|
13.26%
|
13.31%
|
11.35%
|
8.3%
|
10.15%
|
9.43%
|
10.29%
|
9.87%
|
Earnings before Tax (EBT)
1 |
47.83
|
72.43
|
45.18
|
40.15
|
63.11
|
64.5
|
73.5
|
78.9
|
Net income
1 |
38.21
|
55.56
|
34.78
|
22.38
|
50.47
|
51.2
|
58.45
|
62.2
|
Net margin
|
10.47%
|
13.66%
|
7.96%
|
4.54%
|
9.14%
|
8.1%
|
8.53%
|
8.32%
|
EPS
2 |
3,520
|
5,102
|
3,142
|
1,891
|
4,120
|
4,273
|
4,867
|
-
|
Free Cash Flow
3 |
22,863
|
8,789
|
-
|
-
|
-
|
34,000
|
46,000
|
-
|
FCF margin
|
6,263.58%
|
2,161.22%
|
-
|
-
|
-
|
5,381.45%
|
6,716.31%
|
-
|
FCF Conversion (EBITDA)
|
39,260.68%
|
13,326.09%
|
-
|
-
|
-
|
40,816.33%
|
50,438.6%
|
-
|
FCF Conversion (Net income)
|
59,840.63%
|
15,818.72%
|
-
|
-
|
-
|
66,406.25%
|
78,699.74%
|
-
|
Dividend per Share
2 |
578.5
|
545.5
|
600.0
|
600.0
|
630.0
|
630.0
|
615.0
|
630.0
|
Announcement Date
|
3/11/20
|
2/15/21
|
2/16/22
|
2/14/23
|
3/20/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
112.3
|
113.7
|
-
|
124.1
|
123.1
|
129.3
|
127.9
|
138.2
|
145.2
|
147.8
|
160.4
|
157.2
|
166.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
14.73
|
8.681
|
-
|
10.87
|
2.025
|
16.25
|
11.19
|
14.95
|
11.99
|
10.69
|
18.2
|
16.1
|
14.6
|
Operating Margin
|
13.13%
|
7.63%
|
-
|
8.76%
|
1.64%
|
12.56%
|
8.75%
|
10.82%
|
8.25%
|
7.24%
|
11.35%
|
10.24%
|
8.77%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
14.28
|
-
|
8.728
|
-
|
-
|
-
|
-
|
-
|
-
|
9.881
|
12.5
|
14.3
|
15.4
|
Net margin
|
12.72%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
6.69%
|
7.79%
|
9.1%
|
9.25%
|
EPS
|
-
|
-
|
717.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/15/21
|
2/16/22
|
5/16/22
|
8/9/22
|
11/4/22
|
2/14/23
|
5/4/23
|
11/14/23
|
3/20/24
|
5/10/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
34.1
|
-
|
-
|
50.7
|
46
|
22.6
|
-
|
Net Cash position
1 |
20.2
|
-
|
27.8
|
-
|
-
|
-
|
-
|
10.7
|
Leverage (Debt/EBITDA)
|
-
|
0.5165
x
|
-
|
-
|
0.9047
x
|
0.5522
x
|
0.2478
x
|
-
|
Free Cash Flow
2 |
22,863
|
8,789
|
-
|
-
|
-
|
34,000
|
46,000
|
-
|
ROE (net income / shareholders' equity)
|
21.4%
|
25.7%
|
13.4%
|
8.16%
|
16.6%
|
14.7%
|
14.7%
|
13.9%
|
ROA (Net income/ Total Assets)
|
13.9%
|
15.8%
|
8.11%
|
4.92%
|
10%
|
9.1%
|
9.7%
|
9.3%
|
Assets
1 |
275.9
|
351.2
|
428.7
|
454.8
|
505
|
562.6
|
602.6
|
668.8
|
Book Value Per Share
3 |
17,920
|
20,170
|
24,733
|
23,874
|
27,406
|
30,813
|
35,135
|
-
|
Cash Flow per Share
3 |
-
|
4,246
|
-
|
-
|
4,250
|
5,831
|
6,446
|
-
|
Capex
1 |
19.3
|
37.7
|
40.7
|
41.3
|
-
|
35
|
23.8
|
26.6
|
Capex / Sales
|
5.28%
|
9.27%
|
9.31%
|
8.39%
|
-
|
5.54%
|
3.47%
|
3.56%
|
Announcement Date
|
3/11/20
|
2/15/21
|
2/16/22
|
2/14/23
|
3/20/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
33,800
KRW Average target price
54,000
KRW Spread / Average Target +59.76% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.98% | 294M | | +37.80% | 705B | | +32.82% | 583B | | -3.67% | 364B | | +20.21% | 332B | | +4.89% | 291B | | +16.64% | 238B | | -4.13% | 210B | | +10.63% | 209B | | +8.81% | 169B |
Other Pharmaceuticals
|